XLV vs IXJ
YTDYear to date
XLV wins+1.3 pts
Past year
XLV wins+1.0 pt
Fee
XLV winslower fee
Yield
XLV wins+0.1 pts
AUM
XLV10.3× more
4–0XLV wins
XLV and IXJ · year-to-date · as of Nov 5, 2026 · AUM not scored
IXJ vs S&P 500
1D$115.53 · +3.2% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D ▼1M3MYTD1Y3Y5YMAX
Total return+3.2%+14.0%+14.1%+19.7%+28.6%+53.0%+43.9%+480.6%
Peer average−3.4%+4.6%+3.5%+19.7%+29.0%+75.3%+27.3%—
S&P 500 · VOO−4.4%−5.7%−4.9%+8.4%+9.8%+82.2%+71.6%+790.6%
iShares IXJ and Vanguard VOO · total return, dividends in · as of Nov 5, 2026
IXJ’s Holdings
TodayLLYEli Lilly11.4%JNJ6.7%ABBV5.2%MRK4.1%UNH4.0%ROP.SW3.7%NOVN.SW3.3%AZN.L3.2%TMO2.9%AMGN2.8%GILD2.4%ABT2.2%PFE1.9%ISRG1.9%DHR1.6%VRTX1.5%NOVO-B.CO1.5%BMY1.4%MDT1.4%MCK1.4%87 more
LLYEli Lilly11.4%JNJ6.7%ABBV5.2%MRK4.1%UNH4.0%ROP.SW3.7%NOVN.SW3.3%AZN.L3.2%TMO2.9%AMGN2.8%GILD2.4%97 more
Drug Manufacturers - GeneralMedical - DevicesMedical - DiagnosticsMedical - Healthcare PlansBiotechnologyMedical - InstrumentsOther
iShares IXJ · 109 holdings · tile size = share of the fund · as of Nov 5, 2026
All 39 Health Care ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.4% | +20.9% | +20.9% | $49.1B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.4% | +19.7% | +19.7% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.4% | +21.8% | +21.8% | $10.6B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +20.3% | +20.3% | $4.9B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.2% | +19.7% | +19.7% | $4.7B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.4% | −2.7% | −2.7% | $4.1B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.2% | +20.0% | +20.0% | $3.5B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +54.0% | +54.0% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.4% | +25.6% | +25.6% | $1.7B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +24.9% | +24.9% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +22.8% | +22.8% | $1.2B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.7% | +31.5% | +31.5% | $1.2B | |
| 13 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +17.4% | +17.4% | $1.2B | |
| 14 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +22.1% | +22.1% | $1.2B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +21.9% | +21.9% | $579M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +32.6% | +32.6% | $538M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 5, 2026
IXJ Payouts by Year
13YLatest payout, Jun 2026
$0.85
a share · twice a year
1.2% yield
1.2% yield
13 years added up
$13.64 a share
$13.64 a share
iShares IXJ · per-share distributions by ex-date · 2014–2026
IXJ’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.4% | −2.5% | +20.9% | +29.6% | $49.1B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.4% | −2.9% | +19.7% | +28.0% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.4% | −6.7% | +21.8% | +37.9% | $10.6B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | −2.8% | +20.3% | +28.8% | $4.9B | |
| 5 | IXJ | iShares Global Healthcare ETFThis fund | 0.38% | 1.2% | +3.2% | +19.7% | +28.6% | $4.7B | |
| 6 | IHI | iShares U.S. Medical Devices ETFReadVersus | 0.37% | 0.4% | +6.7% | −2.7% | −0.4% | $4.1B |
#18 of 33 this year · #19 cheapest of 39 · sorted by assetsOpen the Sectors table →
IXJ and its peer group · total return · as of Nov 6, 2026
Cards for This View
IXJ’s Top 10 Holdings
Today47.4%of IXJ sits in these 10
7NOVN.SNovartis Ag3.31%
iShares IXJ · weight in the fund · as of Nov 5, 2026
IXJ’s Holdings
TodayLLYEli Lilly11.4%JNJ6.7%ABBV5.2%MRK4.1%UNH4.0%ROP.SW3.7%NOVN.SW3.3%AZN.L3.2%TMO2.9%AMGN2.8%GILD2.4%ABT2.2%PFE1.9%ISRG1.9%DHR1.6%VRTX1.5%NOVO-B.CO1.5%BMY1.4%MDT1.4%MCK1.4%87 more
LLYEli Lilly11.4%JNJ6.7%ABBV5.2%MRK4.1%UNH4.0%ROP.SW3.7%NOVN.SW3.3%AZN.L3.2%TMO2.9%AMGN2.8%GILD2.4%97 more
Drug Manufacturers - GeneralMedical - DevicesMedical - DiagnosticsMedical - Healthcare PlansBiotechnologyMedical - InstrumentsOther
iShares IXJ · 109 holdings · tile size = share of the fund · as of Nov 5, 2026
IXJ vs Peer Average
YTDIXJAvsBPeer average
1D+3.2%−3.4%
1M+14.0%+4.6%
3M+14.1%+3.5%
YTD+19.7%+19.7%
1Y+28.6%+29.0%
3Y+53.0%+75.3%
5Y+43.9%+27.3%
4–3IXJ wins
38 Health care peers · each row scaled to its leader